Searchable abstracts of presentations at key conferences in endocrinology

ea0013p125 | Growth and development | SFEBES2007

Inflammatory cytokines in juvenile idiopathic arthritis: Effects on physical growth and in vitro longitudinal bone growth

Wong SC , MacRae VE , Smith W , Gracie JA , McInnes IB , Galea P , Gardner-Medwin J , Ahmed SF

Background: Inflammatory cytokines in children with juvenile idiopathic arthritis (JIA) may modulate growth through systemic and local mechanisms.Aims: To study the relationship between inflammatory cytokines in serum /synovial fluid (SF) with growth and to assess the effects of serum/SF on the fetal rat metatarsal model.Subjects & Methods: 17 children with JIA (F,10): 8 oligoarticular, 2 extended oligoarticular, 6 polyarticula...

ea0073oc3.4 | Oral Communications 3: Pituitary and Neuroendocrinology | ECE2021

Truncated somatostatin receptor variant SST5TMD4 determines somatostatin analogs response in corticotropinomas

Alejandro Ibáñez-Costa , Vázquez-Borrego Mari C. , Moreno-Moreno Paloma , Fuentes-Fayos Antonio C. , Moreno Eva Venegas , Fuentes-Fayos Juan Antonio , Herrera-Martínez Aura D. , Gahete Ortiz Manuel , Soto-Moreno Alfonso , Gálvez-Moreno Ángeles María , Luque Raul M. , Castaño Justo P.

IntroductionCushing’s disease is the result of prolonged exposure to excess cortisol caused by a pituitary tumor, known as corticotropinoma, which hypersecretes adrenocorticotropin (ACTH). Treatment with somatostatin analogs (SSA) has been shown to reduce hormone secretion and, to a lower extent, tumor growth in some subtypes of pituitary tumors, such as growth hormone secreting tumors. However, SSA are commonly ineffective in corticotropinomas. Pre...

ea0073oc9.3 | Oral Communications 9: Endocrine-Related Cancer | ECE2021

Dysregulation of alternative splicing unveils new avenues for targeting pulmonary carcinoids

Blázquez-Encinas Ricardo , Teresa Caro María , García-Vioque Víctor , Pedraza-Arévalo Sergio , Alors-Pérez Emilia , Dulcínea Herrera-Martínez Aura , Sánchez-Sánchez Rafael , Serrano-Blanch Raquel , Foll Matthieu , Fernández-Cuesta Lynnette , D Gahete Manuel , M Luque Raúl , Ibáñez-Costa Alejandro , P Castaño Justo

IntroductionDysregulation of alternative splicing is emerging as a new hallmark of cancer. This dysregulation may originate from mutations and/or altered expression of specific components of the splicing machinery. Indeed, our group has shown that the expression profile of the splicing machinery is altered in several types of cancer, including endocrine-related cancers. However, to date, the status of alternative splicing and its putative dysregulation h...